We've all seen and been reading / talking about the value comparisons that the US market puts on promising biotech stocks , compared to the Australian market .
Other posters have made comments that if IMC was a US listed company it would have a market cap of 10 times the current cap ( and this was assuming the latest NASH results were positive )
Well it seems to me the results were extremely positive
So what is the reaction going to be in the US ???
Better still what is the reaction going to be in the US once the "industry" has read and digested the implications of what IMC are doing ? Say in a week or two ...or few months time ???
I think I know the answer to that question !!!
Interesting times ahead for sure .
cheers
VA
Add to My Watchlist
What is My Watchlist?
